Heat shock cognate protein 70 (Hsc70) acts as a molecular chaperone for the maintenance of intracellular proteins, which allows cancer cells to survive under proteotoxic stress. We attempted to use Hsc70 to identify key molecules in cancer cell survival. Here, we performed mass-spectrometry-based proteomics analysis utilizing affinity purification with anti-Hsc70 antibodies; as a result, 83 differentially expressed proteins were identified under stress conditions. This result implies that there was a change in the proteins with which Hsc70 interacted in response to stress. Among the proteins identified under both serum-depleted and 5-fluorouracil-treated conditions, Rab1A was identified as an essential molecule for cancer cell survival. Hsc70 interacted with Rab1A in a chaperone-dependent manner. In addition, Hsc70 knockdown decreased the level of Rab1A and increased the level of its ubiquitination under stress conditions, suggesting that Hsc70 prevented the degradation of Rab1A denatured by stress exposure. We also found that Rab1A knockdown induced cell death by inhibition of autophagosome formation. Rab1A may therefore contribute to overcoming proteotoxic insults, which allows cancer cells to survive under stress conditions. Analysis of Hsc70 interactors provided insight into changes of intracellular status. We expect further study of the Hsc70 interactome to provide a more comprehensive understanding of cancer cell physiology.
References
[1]
Bukau B, Horwich AL (1998) The Hsp70 and Hsp60 chaperone machines. Cell 92: 351–366. doi: 10.1016/s0092-8674(00)80928-9
[2]
Daugaard M, Rohde M, Jaattela M (2007) The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. Febs Letters 581: 3702–3710. doi: 10.1016/j.febslet.2007.05.039
[3]
Mayer MP, Bukau B (2005) Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 62: 670–684. doi: 10.1007/s00018-004-4464-6
[4]
Tyedmers J, Mogk A, Bukau B (2010) Cellular strategies for controlling protein aggregation. Nature Reviews Molecular Cell Biology 11: 777–788. doi: 10.1038/nrm2993
[5]
Moran DM, Shen H, Maki CG (2009) Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes. BMC Cell Biol 10: 32. doi: 10.1186/1471-2121-10-32
[6]
Murphy ME (2013) The HSP70 family and cancer. Carcinogenesis 34: 1181–1188. doi: 10.1093/carcin/bgt111
[7]
Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, et al. (2005) Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes & Development 19: 570–582. doi: 10.1101/gad.305405
[8]
Ren A, Yan G, You B, Sun J (2008) Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells. Cancer Res 68: 2266–2274. doi: 10.1158/0008-5472.can-07-6248
[9]
Pocaly M, Lagarde V, Etienne G, Ribeil JA, Claverol S, et al. (2007) Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia. Leukemia 21: 93–101. doi: 10.1038/sj.leu.2404463
[10]
Teng Y, Ngoka L, Mei Y, Lesoon L, Cowell JK (2012) HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein. J Biol Chem 287: 10051–10059. doi: 10.1074/jbc.m111.335000
[11]
Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86–103. doi: 10.1379/csc-99r.1
[12]
Powers MV, Workman P (2007) Inhibitors of the heat shock response: Biology and pharmacology. Febs Letters 581: 3758–3769. doi: 10.1016/j.febslet.2007.05.040
[13]
Leu JI, Pimkina J, Frank A, Murphy ME, George DL (2009) A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 36: 15–27. doi: 10.1016/j.molcel.2009.09.023
[14]
Goloudina AR, Demidov ON, Garrido C (2012) Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett 325: 117–124. doi: 10.1016/j.canlet.2012.06.003
[15]
Jego G, Hazoume A, Seigneuric R, Garrido C (2013) Targeting heat shock proteins in cancer. Cancer Lett 332: 275–285. doi: 10.1016/j.canlet.2010.10.014
[16]
Liu T, Daniels CK, Cao S (2012) Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential. Pharmacol Ther 136: 354–374. doi: 10.1016/j.pharmthera.2012.08.014
[17]
Florin L, Becker KA, Sapp C, Lambert C, Sirma H, et al. (2004) Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. Journal of Virology 78: 5546–5553. doi: 10.1128/jvi.78.11.5546-5553.2004
[18]
Bristow RG, Hill RP (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8: 180–192. doi: 10.1038/nrc2344
[19]
Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437–447. doi: 10.1038/nrc1367
[20]
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57–70. doi: 10.1016/s0092-8674(00)81683-9
[21]
Taddei ML, Giannoni E, Comito G, Chiarugi P (2013) Microenvironment and tumor cell plasticity: An easy way out. Cancer Lett.
[22]
Luo J, Solimini NL, Elledge SJ (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136: 823–837. doi: 10.1016/j.cell.2009.02.024
[23]
Maeda A, Ohguro H, Maeda T, Wada I, Sato N, et al. (2000) Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res 60: 1914–1920.
[24]
Kodiha M, Chu A, Lazrak O, Stochaj U (2005) Stress inhibits nucleocytoplasmic shuttling of heat shock protein hsc70. Am J Physiol Cell Physiol 289: C1034–1041. doi: 10.1152/ajpcell.00590.2004
[25]
Shiota M, Saiwai H, Mun S, Harada A, Okada S, et al. (2010) Generation of a rat monoclonal antibody specific for heat shock cognate protein 70. Hybridoma (Larchmt) 29: 453–456. doi: 10.1089/hyb.2010.0024
[26]
Steel R, Cross RS, Ellis SL, Anderson RL (2012) Hsp70 architecture: the formation of novel polymeric structures of Hsp70.1 and Hsc70 after proteotoxic stress. PLoS One 7: e52351. doi: 10.1371/journal.pone.0052351
[27]
Liu B, Han Y, Qian SB (2013) Cotranslational response to proteotoxic stress by elongation pausing of ribosomes. Mol Cell 49: 453–463. doi: 10.1016/j.molcel.2012.12.001
[28]
Shiota M, Tanihiro T, Nakagawa Y, Aoki N, Ishida N, et al. (2003) Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormone. Mol Endocrinol 17: 534–549. doi: 10.1210/me.2002-0187
[29]
Shiota M, Kusakabe H, Izumi Y, Hikita Y, Nakao T, et al. (2009) Heat Shock Cognate Protein 70 Is Essential for Akt Signaling in Endothelial Function. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 491–497. doi: 10.1161/atvbaha.109.193631
[30]
Kakehashi A, Ishii N, Shibata T, Wei M, Okazaki E, et al. (2011) Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis. Toxicol Sci 119: 61–72. doi: 10.1093/toxsci/kfq307
[31]
Gluckmann M, Fella K, Waidelich D, Merkel D, Kruft V, et al. (2007) Prevalidation of potential protein biomarkers in toxicology using iTRAQ reagent technology. Proteomics 7: 1564–1574. doi: 10.1002/pmic.200600836
[32]
Gabai VL, Yaglom JA, Waldman T, Sherman MY (2009) Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol 29: 559–569. doi: 10.1128/mcb.01041-08
[33]
Zhang L, Fok JJ, Mirabella F, Aronson LI, Fryer RA, et al.. (2013) Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress. Cancer Lett.
[34]
Clarke PR, Zhang C (2001) Ran GTPase: a master regulator of nuclear structure and function during the eukaryotic cell division cycle? Trends Cell Biol 11: 366–371. doi: 10.1016/s0962-8924(01)02071-2
[35]
Quimby B (2003) The small GTPase Ran: interpreting the signs. Current Opinion in Cell Biology 15: 338–344. doi: 10.1016/s0955-0674(03)00046-2
[36]
Tietze N, Pelisek J, Philipp A, Roedl W, Merdan T, et al. (2008) Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran. Oligonucleotides 18: 161–174. doi: 10.1089/oli.2008.0112
[37]
Yuen HF, Chan KK, Grills C, Murray JT, Platt-Higgins A, et al. (2012) Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. Clin Cancer Res 18: 380–391. doi: 10.1158/1078-0432.ccr-11-2035
[38]
Saitoh H, Cooke CA, Burgess WH, Earnshaw WC, Dasso M (1996) Direct and indirect association of the small GTPase ran with nuclear pore proteins and soluble transport factors: studies in Xenopus laevis egg extracts. Mol Biol Cell 7: 1319–1334. doi: 10.1091/mbc.7.9.1319
[39]
Mizushima N, Yoshimori T (2007) How to interpret LC3 immunoblotting. Autophagy 3: 542–545.
[40]
Zoppino FC, Militello RD, Slavin I, Alvarez C, Colombo MI (2010) Autophagosome formation depends on the small GTPase Rab1 and functional ER exit sites. Traffic 11: 1246–1261. doi: 10.1111/j.1600-0854.2010.01086.x
[41]
Martinez O, Goud B (1998) Rab proteins. Biochimica Et Biophysica Acta-Molecular Cell Research 1404: 101–112. doi: 10.1016/s0167-4889(98)00050-0
[42]
Mathew R, Karantza-Wadsworth V, White E (2007) Role of autophagy in cancer. Nat Rev Cancer 7: 961–967. doi: 10.1038/nrc2254
[43]
Zhai H, Song B, Xu X, Zhu W, Ju J (2012) Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene 32: 1570–1579. doi: 10.1038/onc.2012.167
[44]
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, et al. (2005) Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92: 1915–1921.
[45]
Kaushik S, Cuervo AM (2012) Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 22: 407–417. doi: 10.1016/j.tcb.2012.05.006
